Total Number of Communication Reports: 23
Monthly communication reports in the last 6 months: 0
Biotechnology, data, life sciences and genetic research
Christopher Gardner, CEO
End date of the last completed financial year: 2017-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Atlantic Canada Opportunities Agency (ACOA) | $253,720.00 | Yes |
National Research Council (NRC) | $283,878.00 | Yes |
Address:
139 Water St.
St. John's, NL A1B 3T2
Canada
Telephone number:
800-296-3481
Sequence Bio is not a subsidiary of any other parent companies.
Sequence Bio does not have any subsidiaries that could have a direct interest in the outcome of the undertaking